Getinge (STO: GETI-B) revenue
Getinge reported revenue of SEK 34,969m for fiscal 2025, 0.6% more than in fiscal 2024 (SEK 34,759m). Since fiscal 2020 its revenue has grown by 17.3%, an average growth of 3.2% a year.
Getinge has grown its revenue for 4 years in a row, and fiscal 2025 is the highest of its 6 fiscal years on record. The biggest drop was in fiscal 2021, −9.3%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | SEK 34,969m | +0.6% | SEK 3,789m | 10.8% |
| 2024 | SEK 34,759m | +9.2% | SEK 2,854m | 8.2% |
| 2023 | SEK 31,827m | +12.5% | SEK 3,736m | 11.7% |
| 2022 | SEK 28,292m | +4.6% | SEK 3,626m | 12.8% |
| 2021 | SEK 27,049m | −9.3% | SEK 4,371m | 16.2% |
| 2020 | SEK 29,819m | — | SEK 4,784m | 16.0% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of Swedish kronor, except per-share amounts.
Getinge revenue compared with its sector
By revenue for its latest fiscal year, Getinge ranks 14th of the 59 Spanish and European health care companies with a page on Celsmar. The sector median grew 4.5% in its latest fiscal year; Getinge, 0.6%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 12th | Coloplast | DKK 27,874m | 3.1% |
| 13th | Genmab | $3,720m | 19.2% |
| 14th | Getinge | SEK 34,969m | 0.6% |
| 15th | Demant | DKK 22,971m | 2.5% |
| 16th | Hikma Pharmaceuticals | $3,349m | 7.1% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in health care stocks.
Questions about the revenue of Getinge
- How much revenue did Getinge make in fiscal 2025?
- Getinge reported revenue of SEK 34,969m for fiscal 2025, compared with SEK 34,759m in fiscal 2024.
- How much has the revenue of Getinge grown?
- Between fiscal 2020 and fiscal 2025 it went from SEK 29,819m to SEK 34,969m: 17.3% more, an average growth of 3.2% a year.
- What was the best year for revenue at Getinge?
- Of its last 6 fiscal years, fiscal 2025, with SEK 34,969m.
- Where does Getinge rank in its sector by revenue?
- It ranks 14th of the 59 Spanish and European health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Getinge come from?
- From the report Getinge files every year in the European single electronic format (ESEF), the one it files with the regulator of its home market. Each fiscal year links to its filing.
Where each figure comes from
From the annual report Getinge files every year in the European single electronic format (ESEF). The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021. More on Getinge: the Getinge page · annual accounts · net income · dividends paid.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.